Friday 6 November 2026 Export COR’s income statement to Excel — free account

Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.

Revenue: +5.52%
EPS: +258.4%
Free cash flow: −7.81%
Total debt: +47.1%

Quarter to September 2026, against a year earlier

334.79 4.89 −1.44%

Follow COR

Alert me

Market cap: $64.8B
P/E: 18.8×
Fwd P/E: 17.5×
Dividend yield: 0.71%
F-score: 7/9
Altman Z: n/a
Beneish M: −2.59
Dividend safety: 70/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Cencora, Inc. (COR) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Cencora, Inc. (COR) trades at a price to free cash flow of 16.7×. Over the past ten years it has ranged from 0.0× (March 2025) to 52.4× (September 2025); the current reading is higher than 79% of that period. That is below the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/COR/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Cencora, Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/COR/metrics/price-to-free-cash-flow">Cencora, Inc. (COR) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2026	14.8×	(21.83%)
FY2025	18.9×	26.72%
FY2024	14.9×	41.92%
FY2023	10.5×	(17.85%)
FY2022	12.8×	15.82%
FY2021	11.0×	4.21%
FY2020	10.6×	24.59%
FY2019	8.5×	(54.45%)
FY2018	18.7×	6.48%
FY2017	17.5×	177.52%

Period	Price to free cash flow	Change
Sep 2026	14.8×	10.91%
Jun 2026	13.3×	(65.11%)
Mar 2026	38.2×	112.30%
Dec 2025	18.0×	(4.86%)
43 more quarters	Free account

Against its own ten years

Low 0.0× High 52.4×

Ten-year median 12.6×

Current reading's percentile 79

Company	Price to free cash flow
ACH Accendra Health, Inc. compare	n/m
FOCL FocalTherics compare	n/m
YI 111, Inc. Sponsored ADR compare	n/m
AHG Akso Health Group Sponsored ADR compare	n/m
COSM Cosmos Health Inc. compare	n/m
CAH Cardinal Health, Inc. compare	13.6×
COR Cencora, Inc.	16.7×
HSIC Henry Schein, Inc. compare	17.0×
MCK McKesson Corporation compare	18.2×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Cencora, Inc. (COR) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on COR

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on COR

Stockrow Weekly